Sun Pharmaceutical’s SPARC Unit Hopes To Kindle India Research Pipeline

Sun Pharma’s research unit SPARC shared an update of its research pipeline, but analysts are short on excitement, owing mostly to delays on timelines.

More from India

More from Focus On Asia